Skip to main content
POOLBEG PHARMA PLC logo

POOLBEG PHARMA PLC — Investor Relations & Filings

Ticker · POLB ISIN · GB00BKPG7Z60 LEI · 213800UZ8WJLWYHBFL52 IL Manufacturing
Open in API
Filings indexed 160 across all filing types
Latest filing 2021-10-14 Regulatory Filings
Country GB United Kingdom
Listing IL POLB

About POOLBEG PHARMA PLC

https://poolbegpharma.com/

Poolbeg Pharma PLC is a clinical-stage biopharmaceutical company that develops and commercializes medicines for diseases with high unmet medical needs. The company's lead asset, POLB 001, is a treatment designed to prevent Cytokine Release Syndrome (CRS), a severe side effect associated with cancer immunotherapies, with the aim of making these treatments safer and more accessible. Poolbeg is also advancing an oral GLP-1 program for obesity, offering a patient-friendly therapeutic option. The company utilizes an artificial intelligence (AI)-led discovery platform that analyzes data from human challenge trials to identify novel drug targets. This AI-driven approach aims to accelerate target identification, reduce costs, and lower development risks.

Recent filings

Filing Released Lang Actions
PredictViral Patent Update
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 0166P' and is dated '14 October 2021'. It discusses a 'PredictViral™ Patent update' regarding new patent filings. The text concludes with standard boilerplate information referencing 'RNS, the news service of the London Stock Exchange' and the FCA. This structure strongly indicates a general regulatory announcement disseminated via the RNS system, rather than a specific financial report (like 10-K, IR, ER) or a formal meeting material (like AGM-R, DEF 14A). Since it is a general regulatory announcement that doesn't fit the other specific categories (like DIRS, DIV, CAP), the most appropriate fallback is Regulatory Filings (RNS). The document length is moderate (5926 chars), but its nature is purely informational/announcement-based, not a comprehensive report.
2021-10-14 English
RNA sequencing ahead of AI analysis programme
Environmental & Social Information Classification · 1% confidence The document begins with 'RNS Number : 2790O' and is dated '07 October 2021'. It contains general company news regarding a partnership with Eurofins for RNA sequencing ahead of an AI analysis program for RSV drug targets. The structure, the presence of the RNS number, and the nature of the announcement (a general operational update/partnership announcement) strongly suggest this is a regulatory news service release from the London Stock Exchange. Since it is a general regulatory announcement that doesn't fit specific categories like Director's Dealing (DIRS), Dividend (DIV), or Earnings Release (ER), the most appropriate classification is the general regulatory filing category, RNS.
2021-10-07 English
September and October Investor conferences
Report Publication Announcement Classification · 1% confidence The document is identified by the RNS Number header and contains an announcement from Poolbeg Pharma PLC dated September 13, 2021. The content explicitly states that members of management will be attending four upcoming investor events (conferences/webinars) in September and October 2021. This is an announcement about future investor engagement, not the release of a formal financial report (like 10-K or IR) or the results of a vote (DVA). Since it is a general announcement distributed via the RNS system, and it details management's plans to present company information to investors, it aligns best with an Investor Presentation (IP) announcement or a general Regulatory Filing (RNS). Given the context of announcing attendance at investor events where presentations will occur, 'Investor Presentation' (IP) is a strong candidate, but the document itself is an announcement *about* attending events, not the presentation material itself. However, the document is distributed via RNS and is a general corporate update. Since it is not a specific financial report, a management change, or a dividend notice, and it is distributed through the RNS system, the most appropriate general classification for an announcement of this nature that doesn't fit a more specific category like ER or MDA is RNS, especially since it is explicitly labeled as 'RNS Reach' and the text confirms it is a non-regulatory press release distribution service.
2021-09-13 English
POLB001 US Patent Update
Regulatory Filings Classification · 1% confidence The document is identified by the header 'RNS Number : 8972K' and contains an update regarding a US Patent application for a lead product (POLB 001). It discusses intellectual property protection, patent claims, and provides quotes from the CEO. The footer explicitly states, 'This information is provided by Reach, the non-regulatory press release distribution service of RNS... Reach announcements are identified with an orange label...'. This structure strongly indicates a general regulatory announcement or press release distributed via the RNS system, but not a core financial filing like a 10-K or IR. Since the content is an update on IP/legal status rather than a specific financial report, dividend, or management change, and it is distributed via RNS, the most appropriate classification is Regulatory Filings (RNS), which serves as the general announcement/miscellaneous category for non-standard regulatory news.
2021-09-07 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document explicitly starts with 'RNS Number' and contains information about a 'Second Price Monitoring Extension' related to trading on the London Stock Exchange. It concludes by stating, 'This information is provided by RNS, the news service of the London Stock Exchange.' This clearly identifies the document as a general regulatory announcement distributed via the RNS system, which aligns with the definition for Regulatory Filings (RNS). It is not a specific financial report, management change, or dividend notice.
2021-08-23 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Price Monitoring Extension' for a security, which is a specific, short operational announcement related to trading mechanics, not a comprehensive financial report or a standard corporate action like a dividend or earnings release. Given its nature as a general regulatory announcement disseminated via the RNS system and its brevity (1917 chars), it fits best under the general 'Regulatory Filings' category, as it doesn't match any of the more specific financial or corporate event codes (like DIV, ER, 10-K, etc.).
2021-08-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.